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Chronic viral hepatitis is the fifth cause ofmortality in the world. It mainly results from
hepatitis B virus (HBV) and hepatitis C virus (HCV)
infections. This disease can result in critical outcomes
such as cirrhosis, portal hypertension and
hepatocellular carcinoma that impose a significant
economic burden to the health system. Although IV
addiction is the most important route of HCV
acquisition, other routes of transmission such as sexual
contact, contaminated blood transfusion and maternal
route can result in disease spread from infected persons
to others (1, 2).
HCV infection has an old world distribution in
comparison with HIV infection. It is estimated that
about 170 million contaminated cases are in the
world. The prevalence of HCV infection in the
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Seroepidemiology of Hepatitis C in Kermanshah 
(West of Iran, 2006)
Background and Aims: Chronic and serious outcomes of hepatitis C virus (HCV) infection impose a remarkable economic
burden to the health system. The aim of this study was to evaluate the prevalence of HCV infection in the general
population of Kermanshah in the year 2006.
Methods: In this cross-sectional study, 1721 residents from Kermanshah were chosen by systematic and cluster
sampling in the year 2006. After interview, serum samples were taken and evaluated for HCV-Ab using ELISA method
(3rd generation). Positive samples were confirmed by Western Blot (WB) and PCR if necessary.
Results: The prevalence of HCV was 0.87% (male: 1.4% vs. female: 0.3%). There was 88.2% coordination between
ELISA and WB results. Statistical relationship was observed between HCV infection and male sex (P<0.018), history of
addiction (P<0.0001), shared needle (P<0.0001), unsafe sexual contact (P<0.008), history of blood and blood products
transfusion (P<0.0001), tattooing (P<0.0001), history of incarceration (P<0.0001), and hemophilia (P<0.0001). On the
other hand, stepwise logistic regression analysis showed that hemophilia, shared needle, IV addiction, transfusion and
addiction were the most important risk factors for HCV infection in a descending order. The rate of HCV infection
increased in cases with multiple risk factors.
Conclusions: We estimate that among 967196 people, who live in Kermanshah, nearly 8400 individuals may have HCV
infection and this will be a major problem in the near future. Addicts especially IV drug users and cases with the history
of blood and blood products transfusion are high risk groups who need special attention regarding HCV infection.
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general population of developed countries is 1-2% and
less than 0.5% in blood donors (3). Three different
epidemiologic patterns of HCV infection are as
follows: 1) in countries such as the USA and Australia,
most of the HCV infection cases are between 30-49
year old people. It indicates that the majority of HCV
transmission has occurred in recent years, initially
among young adults who are drug users. 2) In areas
such as Japan or southern Europe, the highest
prevalence of HCV infection is among older persons.
In these countries, health related procedures; especially
unsafe injections and traditional medical treatments,
may play the main role in virus transmission. 3) In
countries such as Egypt, high incidence of infection is
seen in all age groups that points to continual
acquisition routs of HCV infection (2-6).
In Iran, studies on the prevalence of HCV infection
in general population have been mainly limited to the
high risk groups. It seems that the prevalence of
hepatitis C in general population is less than 1%,
which is much lower than most of the regional
countries (7). In the first report that appeared in the
literature in 1994, Rezvan et al. from Iranian Blood
Transfusion Organization reported that 0.3% of blood
donors in Tehran had positive anti-HCV antibody (8).
Recently, a study on 5976 blood donors in Rasht,
northern part of Iran, showed that 0.5% of the cases
had positive HCV-Ab (9). In another study, the
prevalence of HCV in hemodialysis patients of
Kermanshah was 26.4% (10). The prevalence and
distribution patterns of HCV infection in the society
are the first steps for planning control programs for it.
Therefore, we decided to evaluate the
seroepidemiology of hepatitis C in the city of
Kermanshah, west of Iran with a population of
967196 people, using the most sensitive and reliable
laboratory methods.
This descriptive cross-sectional study was done on
1721 residents of Kermanshah with an age range of
15-64 in March 2006. Cases were chosen by
systematic and cluster sampling in 144 clusters, each
containing 12 persons. City blocks were chosen
incidentally using a city map and then 144 clusters
were selected for participating in this study. Data was
collected through observation and interview. After
coordination with educated skilful questioner, blood
samplers and the laboratory of Imam Khomeini
Hospital for the reception of the samples, the teams
were sent to the city. After interviewing with persons
who were selected incidentally using cluster sampling
method, blood samples were taken. Persons who did
not want to interview, complete the questionnaire or
donate blood were excluded and other same sex and
same age cases were included from the neighborhood.
Totally, 1796 blood samples were collected and
divided to 1721 cases in the main group and 75 cases
in the reserve group. If the main samples were
unusable for any reason, reserved samples were
substituted. After sampling in 5cc tubes containing
EDTA, samples were sent to the laboratory of Imam
Khomeini Hospital in cold boxes as soon as possible.
Following serum separation, samples were frozen at 
-20°C and then sent to Keyvan Virology Laboratory in
Tehran within 20 days with attention paid to the cold
chain. Primarily, the Spanish 3rd generation ELISA kit
was used. Positive samples reevaluated with the
German diagnostic kit. If the latter was positive, HCV
infection was confirmed. If the report of Western Blot
(WB) was indeterminate, PCR method using
American Amplicor Apparatus was performed for
confirmation or rejection of HCV infection. Finally,
data from the questionnaires and blood test results was
analyzed with SPSS 11.5 using chi-square, Pearson
and Fischer's exact tests.
Prevalence & sex distribution
Among 1721 evaluated persons, 17 cases had
positive HCV-Ab using ELISA. Among them, 14
cases were positive, 1 case was indeterminate and 2
cases were negative for HCV-Ab using WB. PCR
was positive on the indeterminate sample. Totally,
15 cases had HCV infection. According to these
results, the prevalence of hepatitis C in Kermanshah
was calculated to be 0.87%. Because 15 cases out of
17 positive ELISA samples were confirmed by WB
and PCR, there was 88.2% coordination between
ELISA and these confirmatory methods. Among the
total of 1721 cases, there were 854 (49.6%) males
and 867 (50.4%) females (M/F: 0.99). In 854
males, there were 12 HCV infected cases and in 867
females, only 3 cases of HCV infection were found.
There was a statistically significant relationship
between male sex and HCV infection (P<0.018).
Age & occupational distribution
There were 1025 (59.6%) persons under the age
of 35 and 696 (40.4%) persons above it. Among
cases under 35 years of age, 8 (0.8%) persons and
among cases above 35, 6 (0.9%) persons had HCV
infection. There was no statistically significant
relationship between age groups and HCV infection
(P<0.86). Five persons (0.29%) from the total of
1721 cases had high risk jobs (nurse, dentist,
physician, etc.) but none of them had HCV
infection. The highest prevalence of HCV positive
cases were observed in the workers group.
Marital status & education level distribution
There were 1058 (61.5%) married, 625 (36.3%)
single and 38 (2.2%) divorced cases. Nine (0.85%)
Hepatitis C in Kermanshah
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married and six (0.96%) single persons had HCV
infection. There was not a statistically significant
relationship between marital status and HCV
infection (P<0.94). Most of the cases had junior
high school and high school diploma (54.7%). The
highest prevalence of HCV infection was observed
in persons who had primary school education (4
cases, 1.29%). There was no statistically significant
relationship between educational level and HCV
infection (P<0.495).
Addiction & alcohol consumption history
Among all cases, 2.7% did not answer the
question about addiction history while eighty-nine
cases (5.2%) gave positive answers. Among 89
persons with an addiction history, there were eight
cases (9%) of HCV infection. A statistically
significant relationship was observed between
addiction history and HCV infection (P<0.0001).
Twelve addicts (13.5%) had a history of injection.
Six cases of IV drug users (50%) Vs. two cases of
non IV drug addicts (2.6%) had HCV infection.
There was a statistically significant relationship
between route of drug use and HCV infection in
addict persons (P<0.0001). Among 12 IV drug
users, 3 cases (25%) had a history of sharing
needles; they all had HCV infection compared to
33% of IV drug users without a shared needle
history. There was a statistically significant
relationship between sharing needles and HCV
infection (P<0.0001). Among the studied cases, 72
(4.2%) did not answer the question about alcohol
consumption history while 196 persons (11.4%)
gave a positive answer. Six cases (3.1%) with
positive alcohol consumption history and six cases
(0.4%) without this history had HCV infection.
There was a statistically significant relationship
between alcohol consuming and hepatitis C
infection (P<0.0001).
Unsafe sexual contact & blood transfusion history
Among evaluated persons, 351 cases (20.4%)
did not answer the question about unsafe sexual
contact history while 15 cases (0.9%) gave positive
answers. Two of the 15 cases (13.3%) who had
unsafe sexual contact vs. 11 of 1355 cases (0.8%)
who did not have unsafe sexual contact had HCV
infection. There was a statistically significant
relationship between unsafe sexual contact history
and HCV infection in cases who answered this
question (P<0.008). Among studied cases, 95
persons (5.5%) had a history of blood and blood
products transfusion and 6 of them (6.3%) had
HCV infection compared to 9 cases out of those
who did not have a blood and blood products
transfusion history (0.6%). There was a statistically
significant relationship between blood and blood
products transfusion and HCV infection
(P<0.0001).
Surgical, tattooing & incarceration history
Among evaluated persons, 587 (34.1%) cases
had undergone at least one surgery and 7 of them
(1.2%) had HCV infection compared to eight of
1134 cases without a surgical history (0.7%).
There was no statistical significant relationship
between surgery and HCV infection (P<0.303). In
this study, 7 persons (3.8%) out of 182 cases with
tattoos had HCV infection versus 8 of 1539 cases
(0.5%) without tattooing. There was a statistically
significant relationship between tattooing and
HCV infection (P<0.0001).
Among evaluated cases, 50 persons (2.9%) did
not answer the question about having a history of
incarceration but 70 cases (4.1%) gave positive
answers. Seven cases with the history of
incarceration (10%) Vs. 7 cases with no
incarceration history (0.4%) harbored HCV
infection. There was a statistically significant
relationship between incarceration history and
HCV infection in persons who had answered this
question (P<0.0001).
Underlying diseases, dentistry & jaundice history
In our study, 2 cases (0.1%) were thalassemic, 1
case (0.06%) was under hemodialysis and 2 cases
(0.1%) had kidney transplant with no HCV
infection among them. Totally, 2 cases (0.1%) were
hemophilic and both of them had HCV infection.
There was a statistically significant relationship
between hemophilia and HCV infection
(P<0.0001). Among 1298 cases with dental
intervention history, 11 persons (0.8%) had HCV
infection. No statistically significant relationship
was observed between dental intervention and
HCV infection (P<0.526).
In our study 86 cases (5%) had a history of
jaundice in their life and among them 6 persons
(7%) had HCV infection. There was a statistically
significant relationship between jaundice and
HCV infection (P<0.0001). Among studied
persons, 218cases (12.7%) had a history of
jaundice in their family and 1 of them (0.5%) had
HCV infection. No statistically significant
relationship was observed between jaundice in
family and HCV infection (P<0.415).
Number of risk factors & frequency of HCV
infection
The occasions that signified statistically, were
Babak Sayad et al.
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selected as the risk factors for acquisition HCV
infection. Among evaluated cases, some persons
had more than one risk factor. According to this
fact, all studied cases were evaluated considering
the number of risk factors and HCV infection rate
and the results are shown in Table 1. Considering
these calculations, it was observed that with an
increase in the number of risk factors, the
frequency rate of HCV infection also increased
(Figure 1). They had a defective direct correlation
with a statistically significant relationship
(P<0.0001).
Considering multiple risk factors that
yielded statistically significant results in
univariate analysis, multivariate analysis
was performed according to the probable
confounding bias. Among 10 risk factors
confirmed by univariate analysis, only
five of them gave statistically significant
results in multivariate analysis which, in a
descending order, are as follows:
hemophilia, shared needle, IV addiction,
blood transfusion and addiction. More
details are shown in Table 2.
In our study, among a total of 1721
evaluated cases, 15 persons had HCV
infection. Therefore, the overall
prevalence of infection was 0.87% (95%
CI: 0.83-0.90). The prevalence of
hepatitis C has significant differences in
different areas of the world. In previous
studies, the prevalence of HCV infection in the
general population of the developed countries was
1-2% (1), in the general population of Taiwan was
9% (11), in blood donors of Iran was 0.2-1.5% (12)
and in volunteer blood donors of Shiraz was 0.59%
(13). HCV infection prevalence in the general
population of Gabon was 6.5% (14) and in healthy
blood donors of India was 2.4% (15). Therefore the
prevalence of HCV infection in this study is less
than most of the developing countries and is
similar to developed and European countries.
Considering the population in Kermanshah and
the prevalence of HCV infection, it is estimated
that 8400 HCV infected persons are in
Kermanshah. Because 85% of HCV infected cases
become chronic, if the infected cases are not
diagnosed and treated timely, we must be prepared
for the management of at least 7400 patients with
cirrhosis or hepatocellular carcinoma in 2-3
decades. In our evaluation, there was 88.2%
agreement between results of the 3rd generation
ELISA method and confirmatory WB test.
Therefore, using ELISA kits (3rd generation) in
our study showed a good quality and sensitivity.
Evaluation of the relationship between different
factors and the frequency of HCV infection
correlating other studies is discussed in detail and
separately as follows: As explained previously, there
are three epidemiologic patterns in HCV
prevalence according to the age of cases throughout
the world (2-6). In our study, a statistically
significant relationship was not observed between
HCV infection and age which correlates with the
pattern of infection in the third group like the
pattern of infection in Egypt. In one study in
Hepatitis C in Kermanshah
0 risk factor 281 16.33 16.33 1 0.36
1 risk factor 690 40.09 56.42 2 0.29
2 risk factors 480 27.89 84.31 1 0.21
3 risk factors 178 10.34 94.65 2 1.12
4 risk factors 54 3.14 97.79 2 3.70
5 risk factors 23 1.34 99.13 2 8.70
6 risk factors 8 0.46 99.59 1 12.50
7 risk factors 3 0.17 99.77 1 33.33
8 risk factors 3 0.17 99.94 2 66.67
9 risk factors 1 0.06 100.00 1 100.00












Table 1. Frequency of risk factors (simple, relative and
cumulative) considering HCV infection.
Figure 1. HCV infection rate according to the number
of risk factors.
Table 2. Results of multivariate analysis. 
Hemophilia 2 0.008 <0.0001
Shared injection 3 0.006 <0.0001
IV addiction 12 0.005 <0.0001
Blood transfusion 95 0.004 0.004
Addiction 89 0.003 <0.0001
Risk factor Number of cases Odd ratio P value
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Khuzestan (Iran), most of the HCV infected
persons were males (16). In the USA the M/F ratio
in HCV infected cases was 2.5/1.2 (1). In another
study, there was no relationship between sex and
HCV infection in patients who were under
hemodialysis (12). In our study the frequency of
HCV infection was 1.4% in males versus 0.3% in
females. Although it yielded statistically significant
results in univariate analysis (P<0.018), results
were not significant in multivariate analysis. It is
suggested that the relationship between male sex
and hepatitis C results from higher frequency of
risk factors such as IV addiction and unsafe sexual
contact in this group as confounding factors.
In our study, there was a statistically significant
relationship between HCV infection and addiction
versus general population, IV addicted cases vs.
non IV addicted cases, IV addicted persons who
had shared needles history versus those who had
not in both univariate and multivariate analysis
(P<0.0001). In two other studies, both IV drug
addiction and non IV drug addiction were
independent risk factors for hepatitis C (16-18). In
developed countries, most of the new HCV
infections are related to IV drug abuse and it is the
most common risk factor (1, 3). There is correlation
between our study and other series on these
subjects. In this study, the relationship between
HCV infection and alcohol consumption was
statistically significant in univariate analysis
(P<0.0001) but lost its significance in multivariate
analysis. According to other studies, alcohol
consumption, especially more than 50-125g per
day, is suggested as an accelerating factor for the
advancement of fibrosis in patients with chronic
hepatitis C (1, 2, 5) but there are not any studies
about the relationship between HCV infection and
alcohol in the literature.
In our study, the relationship between HCV
infection and unsafe sexual contact was statistically
significant in univariate analysis (P<0.0001) but no
relationship was detected in multivariate analysis.
In some studies, having unsafe sexual contact is
suggested as one of the HCV transmission routs
although it is not the most common rout (1-3, 16, 18).
There was a statistically significant relationship
between HCV infection and blood and blood
products transfusion in both univariate (P<0.0001)
and multivariate analysis (P=0.004). In other
studies, similar relationships were approved in
thalassemic persons (19) and patients under
hemodialysis (12, 20). Blood transfusion from donors
who are not screened is supposed to be an
important risk factor for HCV transmission (1-5).
In this study, the relationship between HCV
infection and tattooing was statistically significant
in univariate analysis (P<0.0001) but lost its
significance in multivariate analysis. Two
investigations correlate with our study on this
subject in hemodialyzed patients (12, 20) but in
other studies, tattooing has been suggested as a risk
factor for HCV transmission (1-6).
In our study, the relationship between HCV
infection and incarceration was statistically
significant in univariate analysis (P<0.0001) but
not in multivariate analysis. In the USA, 20-40%
of prisoners have HCV infection and hepatitis C
has a high prevalence in the prisoners of California,
Maryland and Texas (3). There was a statistically
significant relationship between HCV infection
and hemophilia in both univariate (P<0.0001) and
multivariate analysis (P<0.0001). In others studies,
hemophilic patients belong to high risk groups for
HCV infection (1-5). There is correlation between
our study and other series on this subject. It is
supposed that the high prevalence of HCV
infection in hemophilic patients is related to the
ELISA kits with a low sensitivity in screening
blood. There were not any statistically significant
results in the univariate and multivariate analysis
on the relationship between HCV infection and
occupation, marital status, educational level,
history of surgical and dental procedures,
hemodialysis and kidney transplantation.
According to the previous sections, the results of
this study consist of: 1) In Kermanshah, the
prevalence of HCV infection in the general
population is estimated to be 0.87% (95% CI:
0.83-0.90) which is almost similar to developed
nations. But according to its age distribution (it
was observed in all age groups in our study), it
differs from them. This difference could be the
result of continual acquisition rout of infection. 2)
The most important risk factors of HCV infection
in a descending order are as follows: hemophilia,
shared injection, IV addiction, blood transfusion
and addiction history. 3) In patients who have
more than one risk factor, there is an increasing
chance of HCV infection according to the number
of risk factors. Considering the chronicity and
remarkable economic burden to the health care
system for managing such patients, preventive
cares should be the mainstay of control programs
for this infection. Screening the high risk groups
for HCV infection is an important rout for
detecting HCV infected cases in the general
population.
Babak Sayad et al.
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